Steve McGarry

Stock Analyst at HSBC

(n/a)

# 4,304

Out of 4,667 analysts

4

Total ratings

n/a

Success rate

-29.31%

Average return

Main Sectors:

Top Industries:

Drug Manufacturers - General

Stocks Rated by Steve McGarry

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	GRFS Grifols	Upgrades: Buy	n/a	$8.60	-	2	Mar 11, 2021
	SNY Sanofi	Upgrades: Hold	n/a	$47.78	-	2	Aug 30, 2017

Grifols

Mar 11, 2021

Upgrades: Buy

Price Target: n/a

Current: $8.60

Upside: -

Sanofi

Aug 30, 2017

Upgrades: Hold

Price Target: n/a

Current: $47.78

Upside: -